217 related articles for article (PubMed ID: 28345629)
1. WT1 expression in breast cancer disrupts the epithelial/mesenchymal balance of tumour cells and correlates with the metabolic response to docetaxel.
Artibani M; Sims AH; Slight J; Aitken S; Thornburn A; Muir M; Brunton VG; Del-Pozo J; Morrison LR; Katz E; Hastie ND; Hohenstein P
Sci Rep; 2017 Mar; 7():45255. PubMed ID: 28345629
[TBL] [Abstract][Full Text] [Related]
2. Wilms' tumor protein induces an epithelial-mesenchymal hybrid differentiation state in clear cell renal cell carcinoma.
Sampson VB; David JM; Puig I; Patil PU; de Herreros AG; Thomas GV; Rajasekaran AK
PLoS One; 2014; 9(7):e102041. PubMed ID: 25025131
[TBL] [Abstract][Full Text] [Related]
3. Classification of a frameshift/extended and a stop mutation in WT1 as gain-of-function mutations that activate cell cycle genes and promote Wilms tumour cell proliferation.
Busch M; Schwindt H; Brandt A; Beier M; Görldt N; Romaniuk P; Toska E; Roberts S; Royer HD; Royer-Pokora B
Hum Mol Genet; 2014 Aug; 23(15):3958-74. PubMed ID: 24619359
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor I regulates the expression of isoforms of Wilms' tumor 1 gene in breast cancer.
Tuna M; Itamochi H
Tumori; 2013; 99(6):715-22. PubMed ID: 24503796
[TBL] [Abstract][Full Text] [Related]
5. Wilms' tumor 1 suppressor gene mediates antiestrogen resistance via down-regulation of estrogen receptor-alpha expression in breast cancer cells.
Han Y; Yang L; Suarez-Saiz F; San-Marina S; Cui J; Minden MD
Mol Cancer Res; 2008 Aug; 6(8):1347-55. PubMed ID: 18708366
[TBL] [Abstract][Full Text] [Related]
6. The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancer.
Hanrahan K; O'Neill A; Prencipe M; Bugler J; Murphy L; Fabre A; Puhr M; Culig Z; Murphy K; Watson RW
Mol Oncol; 2017 Mar; 11(3):251-265. PubMed ID: 28133913
[TBL] [Abstract][Full Text] [Related]
7. The transcription factors Tbx18 and Wt1 control the epicardial epithelial-mesenchymal transition through bi-directional regulation of Slug in murine primary epicardial cells.
Takeichi M; Nimura K; Mori M; Nakagami H; Kaneda Y
PLoS One; 2013; 8(2):e57829. PubMed ID: 23469079
[TBL] [Abstract][Full Text] [Related]
8. Correlation of Wilms' tumor 1 isoforms with HER2 and ER-α and its oncogenic role in breast cancer.
Nasomyon T; Samphao S; Sangkhathat S; Mahattanobon S; Graidist P
Anticancer Res; 2014 Mar; 34(3):1333-42. PubMed ID: 24596380
[TBL] [Abstract][Full Text] [Related]
9. The Wilms' tumor suppressor WT1 regulates expression of members of the epidermal growth factor receptor (EGFR) and estrogen receptor in acquired tamoxifen resistance.
Wang L; Zhang X; Wang ZY
Anticancer Res; 2010 Sep; 30(9):3637-42. PubMed ID: 20944147
[TBL] [Abstract][Full Text] [Related]
10. Deducing the stage of origin of Wilms' tumours from a developmental series of Wt1-mutant mice.
Berry RL; Ozdemir DD; Aronow B; Lindström NO; Dudnakova T; Thornburn A; Perry P; Baldock R; Armit C; Joshi A; Jeanpierre C; Shan J; Vainio S; Baily J; Brownstein D; Davies J; Hastie ND; Hohenstein P
Dis Model Mech; 2015 Aug; 8(8):903-17. PubMed ID: 26035382
[TBL] [Abstract][Full Text] [Related]
11. The role of WT1 in breast cancer: clinical implications, biological effects and molecular mechanism.
Zhang Y; Yan WT; Yang ZY; Li YL; Tan XN; Jiang J; Zhang Y; Qi XW
Int J Biol Sci; 2020; 16(8):1474-1480. PubMed ID: 32210734
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-193a inhibits breast cancer proliferation and metastasis by downregulating WT1.
Xie F; Hosany S; Zhong S; Jiang Y; Zhang F; Lin L; Wang X; Gao S; Hu X
PLoS One; 2017; 12(10):e0185565. PubMed ID: 29016617
[TBL] [Abstract][Full Text] [Related]
13. The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells.
Reizner N; Maor S; Sarfstein R; Abramovitch S; Welshons WV; Curran EM; Lee AV; Werner H
J Mol Endocrinol; 2005 Aug; 35(1):135-44. PubMed ID: 16087727
[TBL] [Abstract][Full Text] [Related]
14. Specific kinesin expression profiles associated with taxane resistance in basal-like breast cancer.
Tan MH; De S; Bebek G; Orloff MS; Wesolowski R; Downs-Kelly E; Budd GT; Stark GR; Eng C
Breast Cancer Res Treat; 2012 Feb; 131(3):849-58. PubMed ID: 21479552
[TBL] [Abstract][Full Text] [Related]
15. WT1 and Pax2 re-expression is required for epithelial-mesenchymal transition in 5/6 nephrectomized rats and cultured kidney tubular epithelial cells.
Huang B; Pi L; Chen C; Yuan F; Zhou Q; Teng J; Jiang T
Cells Tissues Organs; 2012; 195(4):296-312. PubMed ID: 21778682
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of the human thromboxane A2 receptor gene by Wilms' tumor (WT)1 and hypermethylated in cancer (HIC) 1 in prostate and breast cancers.
Keating GL; Reid HM; Eivers SB; Mulvaney EP; Kinsella BT
Biochim Biophys Acta; 2014 Jun; 1839(6):476-92. PubMed ID: 24747176
[TBL] [Abstract][Full Text] [Related]
17. Turning back the Wheel: Inducing Mesenchymal to Epithelial Transition via Wilms Tumor 1 Knockdown in Human Mesothelioma Cell Lines to Influence Proliferation, Invasiveness, and Chemotaxis.
Plönes T; Fischer M; Höhne K; Sato H; Müller-Quernheim J; Zissel G
Pathol Oncol Res; 2017 Oct; 23(4):723-730. PubMed ID: 28054314
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of breast cancer cell growth by the Wilms' tumor suppressor WT1 is associated with a destabilization of beta-catenin.
Zhang TF; Yu SQ; Guan LS; Wang ZY
Anticancer Res; 2003; 23(5A):3575-84. PubMed ID: 14666652
[TBL] [Abstract][Full Text] [Related]
19. Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers.
Chen J; Gao S; Wang C; Wang Z; Zhang H; Huang K; Zhou B; Li H; Yu Z; Wu J; Chen C
J Exp Clin Cancer Res; 2016 Nov; 35(1):173. PubMed ID: 27821145
[TBL] [Abstract][Full Text] [Related]
20. Absence of mutations in the Wilms' tumor gene WT1 in primary breast cancer.
Oji Y; Miyoshi Y; Kiyotoh E; Koga S; Nakano Y; Ando A; Hosen N; Tsuboi A; Kawakami M; Ikegame K; Oka Y; Ogawa H; Noguchi S; Sugiyama H
Jpn J Clin Oncol; 2004 Feb; 34(2):74-7. PubMed ID: 15067099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
